Skip to main content

MATTERS develops educational materials for partners and community members to utilize across our networks. Explore our resource library below and use the search function to find what you’re looking for even faster.

22 documents
Cycle of Addiction

Understanding the cycle of addiction can help when addressing substance use disorder.

Exposure to Opioids via Cocaine

Drugs like fentanyl are contaminating stimulants across the United States.

Facts on Fentanyl

Fentanyl is a potent, synthetic opioid that is contaminating other drugs in the U.S. drug supply.

Facts on Xylazine

Xylazine is a potent veterinary tranquilizer that is contaminating opioids across the U.S.

Gas Station Heroin: The Dangers of Tianeptine

Tianeptine is an emerging risk to public health due to its potential for misuse and widespread availability.

Ibogaine

Ibogaine is a naturally occurring substance with hallucinogenic properties.

Kratom

Kratom is a dietary supplement that is widely available and often misused.

Langugae MATTERS

Reduce stigma against people who use drugs (PWUD) by adjusting your language.

Medetomidine

Medetomidine is a potent sedative-analgesic contributing to a recent wave of overdoses.

Myth Busting Fentanyl Exposure

Dispel common myths and misconceptions around fentanyl exposure risks.

Myth Busting Syringe Exchange Programs

Syringe Services are an example of evidence-based harm reduction strategies.

Nitazenes

Nitazenes are synthetic opioids that are considered more potent than fentanyl.

 

Resources for Prescribers

Navigate the documents below to review current prescribing guidelines, exemptions, and frequently asked questions.

4 documents
DEA Instructions

The DEA released instructions on how to request an extension for practitioners administering or dispensing certain medications for opioid use disorder (MOUD).

Notice to Patients: Opioid and Sedative Medications

MATTERS has developed a patient notice for opioid and sedative prescribing to help them understand the risks of misusing these substances.

Opioid and Sedative Prescribing Guidelines

MATTERS provides guidelines for opioid and sedative prescribing for new providers or those who are new to prescribing controlled substances such as buprenorphine.

Prescribing FAQs

Since the repeal of the X-Waiver, many providers are eligible to prescribe buprenorphine to treat opioid use disorder. Learn more about prescribing requirements by navigating our frequently asked questions.